Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
Neoptolemos, John P, Prof, Palmer, Daniel H, Prof, Ghaneh, Paula, Prof, Psarelli, Eftychia E, MSc, Valle, Juan W, MD, Halloran, Christopher M, MD, Faluyi, Olusola, MD, O'Reilly, Derek A, MD, Cunningham, David, Prof, Wadsley, Jonathan, Prof, Darby, Suzanne, MD, Meyer, Tim, Prof, Gillmore, Roopinder, MD, Anthoney, Alan, MD, Lind, Pehr, MD, Glimelius, Bengt, MD, Falk, Stephen, MD, Izbicki, Jakob R, Prof, Middleton, Gary William, MD, Cummins, Sebastian, MD, Ross, Paul J, MD, Wasan, Harpreet, MD, McDonald, Alec, MD, Crosby, Tom, MD, Ma, Yuk Ting, MD, Patel, Kinnari, MD, Sherriff, David, FRCR, Soomal, Rubin, MD, Borg, David, MD, Sothi, Sharmila, MD, Hammel, Pascal, Prof, Hackert, Thilo, MD, Jackson, Richard, PhD, Büchler, Markus W, Prof
Published in The Lancet (British edition) (11.03.2017)
Published in The Lancet (British edition) (11.03.2017)
Get full text
Journal Article
Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas
Ng, Alvin Wei Tian, Contino, Gianmarco, Killcoyne, Sarah, Devonshire, Ginny, Hsu, Ray, Abbas, Sujath, Su, Jing, Redmond, Aisling M, Weaver, Jamie M J, Eldridge, Matthew D, Tavaré, Simon, Edwards, Paul A W, Fitzgerald, Rebecca C
Published in Communications biology (08.04.2022)
Published in Communications biology (08.04.2022)
Get full text
Journal Article
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Jones, Robert P, Psarelli, Eftychia-Eirini, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M, Palmer, Daniel H, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O’Reilly, Derek A, Cunningham, David, Wadsley, Jonathan, Darby, Suzanne, Meyer, Tim, Gillmore, Roopinder, Anthoney, Alan, Lind, Pehr, Glimelius, Bengt, Falk, Stephen, Izbicki, Jakob R, Middleton, Gary William, Cummins, Sebastian, Ross, Paul J, Wasan, Harpreet, McDonald, Alec, Crosby, Tom, Ting, Yuk, Patel, Kinnari, Sherriff, David, Soomal, Rubin, Borg, David, Sothi, Sharmila, Hammel, Pascal, Lerch, Markus M, Mayerle, Julia, Tjaden, Christine, Strobel, Oliver, Hackert, Thilo, Büchler, Markus W, Neoptolemos, John P
Published in JAMA surgery (01.11.2019)
Published in JAMA surgery (01.11.2019)
Get full text
Journal Article
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Frankell, Alexander M, Jammula, SriGanesh, Li, Xiaodun, Contino, Gianmarco, Killcoyne, Sarah, Abbas, Sujath, Perner, Juliane, Bower, Lawrence, Devonshire, Ginny, Ococks, Emma, Grehan, Nicola, Mok, James, O'Donovan, Maria, MacRae, Shona, Eldridge, Matthew D, Tavaré, Simon, Fitzgerald, Rebecca C
Published in Nature genetics (01.03.2019)
Published in Nature genetics (01.03.2019)
Get full text
Journal Article
Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data
Jammula, SriGanesh, Katz-Summercorn, Annalise C., Li, Xiaodun, Linossi, Constanza, Smyth, Elizabeth, Killcoyne, Sarah, Biasci, Daniele, Subash, Vinod V., Abbas, Sujath, Blasko, Adrienn, Devonshire, Ginny, Grantham, Amber, Wronowski, Filip, O’Donovan, Maria, Grehan, Nicola, Eldridge, Matthew D., Tavaré, Simon, Fitzgerald, Rebecca C., Noorani, Ayesha, Edwards, Paul A.W., Grehan, Nicola, Nutzinger, Barbara, Hughes, Caitriona, Fidziukiewicz, Elwira, Bornschein, Jan, MacRae, Shona, Crawte, Jason, Northrop, Alex, Contino, Gianmarco, Li, Xiaodun, de la Rue, Rachel, O’Donovan, Maria, Miremadi, Ahmad, Malhotra, Shalini, Tripathi, Monika, Tavaré, Simon, Lynch, Andy G., Eldridge, Matthew, Secrier, Maria, Bower, Lawrence, Devonshire, Ginny, Perner, Juliane, Jammula, Sriganesh, Davies, Jim, Crichton, Charles, Carroll, Nick, Safranek, Peter, Hindmarsh, Andrew, Sujendran, Vijayendran, Hayes, Stephen J., Ang, Yeng, Preston, Shaun R., Oakes, Sarah, Bagwan, Izhar, Save, Vicki, Skipworth, Richard J.E., Hupp, Ted R., O’Neill, J. Robert, Tucker, Olga, Beggs, Andrew, Taniere, Philippe, Puig, Sonia, Underwood, Timothy J., Noble, Fergus, Owsley, Jack, Barr, Hugh, Shepherd, Neil, Old, Oliver, Lagergren, Jesper, Gossage, James, Davies, Andrew, Chang, Fuju, Zylstra, Janine, Mahadeva, Ula, Goh, Vicky, Ciccarelli, Francesca D., Sanders, Grant, Berrisford, Richard, Harden, Catherine, Lewis, Mike, Cheong, Ed, Kumar, Bhaskar, Parsons, Simon L., Soomro, Irshad, Kaye, Philip, Saunders, John, Lovat, Laurence, Haidry, Rehan, Igali, Laszlo, Scott, Michael, Sothi, Sharmila, Suortamo, Sari, Lishman, Suzy, Hanna, George B., Moorthy, Krishna, Peters, Christopher J., Grabowska, Anna, Turkington, Richard, Fitzgerald, Rebecca C.
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2020)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2020)
Get full text
Journal Article
Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts
Sawas, Tarek, Killcoyne, Sarah, Iyer, Prasad G., Wang, Kenneth K., Smyrk, Thomas C., Kisiel, John B., Qin, Yi, Ahlquist, David A., Rustgi, Anil K., Costa, Rui J., Gerstung, Moritz, Fitzgerald, Rebecca C., Katzka, David A., Noorani, Ayesha, Edwards, Paul A.W., Grehan, Nicola, Nutzinger, Barbara, Hughes, Caitriona, Fidziukiewicz, Elwira, Bornschein, Jan, MacRae, Shona, Crawte, Jason, Contino, Gianmarco, Li, Xiaodun, Rue, Rachel de la, O’Donovan, Maria, Miremad, Ahmad, Malhotra, Shalini, Tripathi, Monika, Tavaré, Simon, Lynch, Andy G., Eldridge, Matthew, Secrier, Maria, Bower, Lawrence, Devonshire, Ginny, Perner, Juliane, Jammula, Sriganesh, Davies, Jim, Crichton, Charles, Carroll, Nick, Safranek, Peter, Hindmarsh, Andrew, Sujendran, Vijayendran, Hayes, Stephen J., Ang, Yeng, Preston, Shaun R., Oakes, Sarah, Bagwan, Izhar, Save, Vicki, Skipworth, Richard J.E., Hupp, Ted R., O’Neill, J. Robert, Tucker, Olga, Beggs, Andrew, Taniere, Philippe, Puig, Sonia, Underwood, Timothy J., Noble, Fergus, Owsley, Jack, Barr, Hugh, Shepherd, Neil, Old, Oliver, Lagergren, Jesper, Gossage, James, Davies, Andrew, Chang, Fuju, Zylstra, Janine, Mahadeva, Ula, Goh, Vicky, Ciccarelli, Francesca D., Sanders, Grant, Berrisford, Richard, Harden, Catherine, Bunting, David, Lewis, Mike, Cheong, Ed, Kumar, Bhaskar, Parsons, Simon L., Soomro, Irshad, Kaye, Philip, Saunders, John, Lovat, Laurence, Haidry, Rehan, Eneh, Victor, Igali, Laszlo, Scott, Michael, Sothi, Sharmila, Suortamo, Sari, Lishman, Suzy, Hanna, George B., Peters, Christopher J., Grabowska, Anna, Turkington, Richard
Published in Gastroenterology (New York, N.Y. 1943) (01.12.2018)
Published in Gastroenterology (New York, N.Y. 1943) (01.12.2018)
Get full text
Journal Article
NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC)
McNamara, Mairead Geraldine, Swain, Jayne, Craig, Zoe, Sharma, Rohini, Faluyi, Olusola Olusesan, Wadsley, Jonathan, Morgan, Carys, Wall, Lucy R., Chau, Ian, Reed, Nick, Sarker, Debashis, Margetts, Jane, Krell, Daniel, Cave, Judith, Sharmila, Sothi, Anthoney, Alan, Patel, Alkesh, Lamarca, Angela, Hubner, Richard, Valle, Juan W.
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy
Craig, Zoe, Swain, Jayne, Sharma, Rohini, Faluyi, Olusola Olusesan, Wadsley, Jonathan, Morgan, Carys, Wall, Lucy R., Chau, Ian, Reed, Nicholas Simon, Sarker, Debashis, Margetts, Jane, Krell, Daniel, Cave, Judith, Sharmila, Sothi, Anthoney, Alan, Patel, Alkesh, Lamarca, Angela, Hubner, Richard A, Valle, Juan W., McNamara, Mairead Geraldine
Published in Journal of clinical oncology (01.10.2022)
Published in Journal of clinical oncology (01.10.2022)
Get full text
Journal Article
NET-02: A multicenter, randomized, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC)
McNamara, Mairead Geraldine, Swain, Jayne, Craig, Zoe, Sharma, Rohini, Faluyi, Olusola Olusesan, Wadsley, Jonathan, Morgan, Carys, Wall, Lucy R., Chau, Ian, Reed, Nick, Sarker, Debashis, Margetts, Jane, Krell, Daniel, Cave, Judith, Sharmila, Sothi, Anthoney, Alan, Patel, Alkesh, Lamarca, Angela, Hubner, Richard A, Valle, Juan W.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Disentangling oncogenic amplicons in esophageal adenocarcinoma
Ng, Alvin Wei Tian, McClurg, Dylan Peter, Wesley, Ben, Zamani, Shahriar A, Black, Emily, Miremadi, Ahmad, Giger, Olivier, Hoopen, Rogier Ten, Devonshire, Ginny, Redmond, Aisling M, Grehan, Nicola, Jammula, Sriganesh, Blasko, Adrienn, Li, Xiaodun, Aparicio, Samuel, Tavaré, Simon, Nowicki-Osuch, Karol, Fitzgerald, Rebecca C
Published in Nature communications (14.05.2024)
Published in Nature communications (14.05.2024)
Get full text
Journal Article
Author Correction: Disentangling oncogenic amplicons in esophageal adenocarcinoma
Ng, Alvin Wei Tian, McClurg, Dylan Peter, Wesley, Ben, Zamani, Shahriar A, Black, Emily, Miremadi, Ahmad, Giger, Olivier, Hoopen, Rogier Ten, Devonshire, Ginny, Redmond, Aisling M, Grehan, Nicola, Jammula, Sriganesh, Blasko, Adrienn, Li, Xiaodun, Aparicio, Samuel, Tavaré, Simon, Nowicki-Osuch, Karol, Fitzgerald, Rebecca C
Published in Nature communications (28.05.2024)
Published in Nature communications (28.05.2024)
Get full text
Journal Article
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma
Abbas, Sujath, Pich, Oriol, Devonshire, Ginny, Zamani, Shahriar A, Katz-Summercorn, Annalise, Killcoyne, Sarah, Cheah, Calvin, Nutzinger, Barbara, Grehan, Nicola, Lopez-Bigas, Nuria, Fitzgerald, Rebecca C, Secrier, Maria
Published in Nature communications (15.07.2023)
Published in Nature communications (15.07.2023)
Get full text
Journal Article
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma
Mourikis, Thanos P, Benedetti, Lorena, Foxall, Elizabeth, Temelkovski, Damjan, Nulsen, Joel, Perner, Juliane, Cereda, Matteo, Lagergren, Jesper, Howell, Michael, Yau, Christopher, Fitzgerald, Rebecca C, Scaffidi, Paola, Ciccarelli, Francesca D
Published in Nature communications (15.07.2019)
Published in Nature communications (15.07.2019)
Get full text
Journal Article
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
Reynolds, John V, Preston, Shaun R, O'Neill, Brian, Lowery, Maeve A, Baeksgaard, Lene, Crosby, Thomas, Cunningham, Moya, Cuffe, Sinead, Griffiths, Gareth O, Parker, Imelda, Risumlund, Signe Lenora, Roy, Rajarshi, Falk, Stephen, Hanna, George B, Bartlett, Frederick R, Alvarez-Iglesias, Alberto, Achiam, Michael P, Nilsson, Magnus, Piessen, Guillaume, Ravi, Narayanasamy, O'Toole, Dermot, Johnston, Ciaran, McDermott, Raymond S, Turkington, Richard C, Wahed, Shajahan, Sothi, Sharmila, Ford, Hugo, Wadley, Martin S, Power, Derek
Published in The lancet. Gastroenterology & hepatology (01.11.2023)
Published in The lancet. Gastroenterology & hepatology (01.11.2023)
Get more information
Journal Article
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
Turkington, Richard C, Knight, Laura A, Blayney, Jaine K, Secrier, Maria, Douglas, Rosalie, Parkes, Eileen E, Sutton, Eilis K, Stevenson, Leanne, McManus, Damian, Halliday, Sophia, McCavigan, Andrena M, Logan, Gemma E, Walker, Steven M, Steele, Christopher J, Perner, Juliane, Bornschein, Jan, MacRae, Shona, Miremadi, Ahmad, McCarron, Eamon, McQuaid, Stephen, Arthur, Kenneth, James, Jacqueline A, Eatock, Martin M, O’Neill, Robert, Noble, Fergus, Underwood, Timothy J, Harkin, D Paul, Salto-Tellez, Manuel, Fitzgerald, Rebecca C, Kennedy, Richard D
Published in Gut (01.11.2019)
Published in Gut (01.11.2019)
Get full text
Journal Article
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
Joharatnam-Hogan, Nalinie, Cafferty, Fay, Hubner, Richard, Swinson, Daniel, Sothi, Sharmila, Gupta, Kamalnayan, Falk, Stephen, Patel, Kinnari, Warner, Nicola, Kunene, Victoria, Rowley, Sam, Khabra, Komel, Underwood, Tim, Jankowski, Janusz, Bridgewater, John, Crossley, Anne, Henson, Verity, Berkman, Lindy, Gilbert, Duncan, Kynaston, Howard, Ring, Alistair, Cameron, David, Din, Farhat, Graham, Janet, Iveson, Timothy, Adams, Richard, Thomas, Anne, Wilson, Richard, Pramesh, C S, Langley, Ruth
Published in The lancet. Gastroenterology & hepatology (01.11.2019)
Published in The lancet. Gastroenterology & hepatology (01.11.2019)
Get more information
Journal Article
Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study
Qureshi, Sheharyar A, Burch, Nicola, Druce, Maralyn, Hattersley, John G, Khan, Saboor, Gopalakrishnan, Kishore, Darby, Catherine, Wong, John L H, Davies, Louise, Fletcher, Simon, Shatwell, William, Sothi, Sharmila, Randeva, Harpal S, Dimitriadis, Georgios K, Weickert, Martin O
Published in BMJ open (04.05.2016)
Published in BMJ open (04.05.2016)
Get full text
Journal Article
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
McNamara, Mairéad G., Swain, Jayne, Craig, Zoe, Sharma, Rohini, Faluyi, Olusola, Wadsley, Jonathan, Morgan, Carys, Wall, Lucy R., Chau, Ian, Reed, Nick, Sarker, Debashis, Margetts, Jane, Krell, Daniel, Cave, Judith, Sothi, Sharmila, Anthoney, Alan, Bell, Christopher, Patel, Alkesh, Oughton, Jamie B., Cairns, David A., Mansoor, Wasat, Lamarca, Angela, Hubner, Richard A., Valle, Juan W.
Published in EClinicalMedicine (01.06.2023)
Published in EClinicalMedicine (01.06.2023)
Get full text
Journal Article
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinomaResearch in context
Mairéad G. McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Jonathan Wadsley, Carys Morgan, Lucy R. Wall, Ian Chau, Nick Reed, Debashis Sarker, Jane Margetts, Daniel Krell, Judith Cave, Sharmila Sothi, Alan Anthoney, Christopher Bell, Alkesh Patel, Jamie B. Oughton, David A. Cairns, Wasat Mansoor, Angela Lamarca, Richard A. Hubner, Juan W. Valle
Published in EClinicalMedicine (01.06.2023)
Get full text
Published in EClinicalMedicine (01.06.2023)
Journal Article
FOLFIRINOX for the treatment of advanced pancreatic cancer: U.K. West Midlands experience
Jain, Ankit, Scott-Brown, Martin, Correa, Peter Denzil, Sothi, Sharmila, Davies, Amy, Candish, Charles, Peake, David, Tsalic, Medy, Punia, Pankaj, Ma, Yuk Ting
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article